Citadel Advisors’s China SXT Pharmaceuticals SXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,014
| Closed | -$17.4K | – | 6678 |
|
|
2024
Q2 | $17.4K | Buy |
+2,014
| New | +$17.4K | ﹤0.01% | 5436 |
|
|
2023
Q4 | – | Sell |
-957
| Closed | -$23.5K | – | 6648 |
|
|
2023
Q3 | $23.5K | Buy |
+957
| New | +$23.5K | ﹤0.01% | 5277 |
|
|
2023
Q2 | – | Sell |
-122
| Closed | -$7.02K | – | 6460 |
|
|
2023
Q1 | $7.02K | Buy |
+122
| New | +$7.02K | ﹤0.01% | 5574 |
|
|
2022
Q2 | – | Sell |
-67
| Closed | -$75K | – | 6882 |
|
|
2022
Q1 | $75K | Buy |
+67
| New | +$75K | ﹤0.01% | 5772 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | -$11K | – | 7162 |
|
|
2021
Q3 | $11K | Sell |
3
-5
| -63% | -$18.3K | ﹤0.01% | 6307 |
|
|
2021
Q2 | $48K | Sell |
8
-5
| -38% | -$30K | ﹤0.01% | 6210 |
|
|
2021
Q1 | $99K | Buy |
+13
| New | +$99K | ﹤0.01% | 5859 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$7K | – | 5242 |
|
|
2020
Q2 | $7K | Sell |
1
-1
| -50% | -$7K | ﹤0.01% | 4561 |
|
|
2020
Q1 | $14K | Buy |
+2
| New | +$14K | ﹤0.01% | 4703 |
|